Sign in
Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial
Journal article   Peer reviewed

Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

Umberto Restelli, Massimiliano Fabbiani, Simona Di Giambenedetto, Carmela Nappi and Davide Croce
ClinicoEconomics and outcomes research, Vol.9, pp.569-571
2017
Scopus ID: 2-s2.0-85032681830
Web of Science ID: WOS:000412367500001
PMID: 29026324
pdf
bitstream_799340d7-4604-4519-9ec0-decb3a672f42146.37 kB
Ask the Library / Chiedi alla Biblioteca Restricted Access

Metrics

22 Record Views

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being